Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−137.70 INR
−5.67 B INR
12.74 B INR
21.60 M
About SOLARA ACTIVE PHA SCI LTD
Sector
CEO
Poorvank Purohit
Headquarters
Chennai
Website
Founded
2017
ISIN
INE624Z01016
FIGI
BBG00G9GRNB7
Solara Active Pharma Sciences Ltd. engages in the manufacture and development of active pharmaceutical ingredient. Its products include Albendazole, aprepitant, artesunate, brivaracetam, bumetanide, buspiron, cetirizine dihydrochloride, chlorpromazine, cinacalcet hydrochloride, citicoline sodium, colchicine, colesevelam, colestipol, cycloserine, dipyridamole, disulfiram, dolutegravir, edaravone, efinaconazole, ethacrynic acid, etomidate, felbamate, flecainide acetate, flucytosine, gabapentin, hydralazine, ibuprofen, imiquimod, indapamide, lanthanum carbonate octahydrate,levetiracetam, lurasidone, mebendazole, mefenamic acid, mesalamine, mesna, methohexital, methoxsalen, mirabegron, mycophenolate mofetil, naproxen base, nizatidine, obeticholic acid, alanzapine, patiromer sorbitex calcium, pentoxifyline, pitavastatin calcium, posaconazole, praziquantel, ranitidine, rebamipide, rifaximin, rotigotine, safinamide, sapropterin, sevelamer carbonate, succinylcholine, sucroferric oxyhydroxide, sugammadex, tioconazole, tranexamic acid and zileuton. The company was founded on February 23, 2017 and is headquartered in Chennai, India.
Solara CMP 522
✔ High Volume at breakout
✔ 2 Years Breakout
✔ Consolidation Before Breakout
Stock is expected target is Rs 670 which is the Range of Consolidation.
Stop Loss is the Swing Higher-Low Rs 355
SOLARA ACTIVE PHARMA LONG TERM VIEWSolara Active Pharma is forming a rounding bottom formation or W pattern on Monthly TimeFrame.
The Entry and Stoploss would be considered on Candle Closing Basis.
Entry - Above 470
Stoploss - Below 273
Target - 1509
( This Target would be achieved in 2 years max from the date of entry).
NOTE:- This
#SOLARA Looking Good for Long-Term Holding around 1 YearStrengths:
Established market position in key APIs, along with strong customer and supplier relationships: Solara has a strong portfolio of APIs in key therapeutic segments, with expertise in anthelmintic, anti-malaria, anti-infective and non-steroidal anti- inflammatory. Furthermore, it has been
Crossover Trade - SOLARA📊 Script: SOLARA
📊 Sector: Pharmaceuticals
📊 Industry: Pharmaceuticals - Indian - Bulk Drugs
Key highlights: 💡⚡
📈 Script is trading at upper band of BB and giving breakout of it.
📈 Already Crossover in Double Moving Averages and MACD.
📈 Right now RSI is around 61.
📈 One can go for Swing Trade.
⏱️
SOLARA AVTIVE PHARMA Solara active Pharmaceutical Create a rounding bottom The stocks are short term create pole flag the short term run stock technical chart or create pole flag general breakout and mid and long term the stocks are create rounding bottom and the stocks are upper side target is 2000+ and The stocks are
SOLARA - BUY ACTIVESOLARA - Solara Active Pharma Sciences Limited - BUY ACTIVE; Chart Insights : Day Chart; We can see stock is coming to break the resistance and expecting good upside move for bigger target. It should break the resistance and sustain above; BUY Active only on top of resistance breaks (490 level) and
The Rising Sun - SOLARA ACTIVE PHARMASolara Active Pharma went thru a Turmoil after its Ex-CEO resigned almost 2 years ago citing reasons for his failure to manage the company's profitability
After the new management took charge - it took 18+ months to stabilize and now to turn the stock to Bullish mode.
Technical Pattern:
On Weekl
Solara - The Sun is Rising Behind the PyramidSolara Active Pharma:
After the CEO of Solara resigned 1.5 years ago, the Company shares faced a major crash - retracing near 100% on Fib scale. A large Pyramid like structure was formed eventually
Over the past few months - the price has started to strengthen the base taking support near the 29
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SOLARA is 761.45 INR — it has increased by 2.13% in the past 24 hours. Watch SOLARA ACTIVE PHA SCI LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange SOLARA ACTIVE PHA SCI LTD stocks are traded under the ticker SOLARA.
SOLARA stock has fallen by −2.35% compared to the previous week, the month change is a −6.69% fall, over the last year SOLARA ACTIVE PHA SCI LTD has showed a 145.89% increase.
We've gathered analysts' opinions on SOLARA ACTIVE PHA SCI LTD future price: according to them, SOLARA price has a max estimate of 566.00 INR and a min estimate of 566.00 INR. Watch SOLARA chart and read a more detailed SOLARA ACTIVE PHA SCI LTD stock forecast: see what analysts think of SOLARA ACTIVE PHA SCI LTD and suggest that you do with its stocks.
SOLARA reached its all-time high on May 19, 2021 with the price of 1,714.20 INR, and its all-time low was 123.95 INR and was reached on Jul 12, 2018. View more price dynamics on SOLARA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SOLARA stock is 2.84% volatile and has beta coefficient of 1.29. Track SOLARA ACTIVE PHA SCI LTD stock price on the chart and check out the list of the most volatile stocks — is SOLARA ACTIVE PHA SCI LTD there?
Today SOLARA ACTIVE PHA SCI LTD has the market capitalization of 36.57 B, it has decreased by −6.71% over the last week.
Yes, you can track SOLARA ACTIVE PHA SCI LTD financials in yearly and quarterly reports right on TradingView.
SOLARA ACTIVE PHA SCI LTD is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
SOLARA net income for the last quarter is 80.10 M INR, while the quarter before that showed −134.60 M INR of net income which accounts for 159.51% change. Track more SOLARA ACTIVE PHA SCI LTD financial stats to get the full picture.
As of Nov 21, 2024, the company has 3.57 K employees. See our rating of the largest employees — is SOLARA ACTIVE PHA SCI LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SOLARA ACTIVE PHA SCI LTD EBITDA is −1.72 B INR, and current EBITDA margin is −22.18%. See more stats in SOLARA ACTIVE PHA SCI LTD financial statements.
Like other stocks, SOLARA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SOLARA ACTIVE PHA SCI LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SOLARA ACTIVE PHA SCI LTD technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SOLARA ACTIVE PHA SCI LTD stock shows the buy signal. See more of SOLARA ACTIVE PHA SCI LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.